Decontamination of cephalosporin-resistant enterobacteriaceae during selective digestive tract decontamination in intensive care units

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 9, 2012, Pages 2250-2253

  Oostdijk, Evelien A N ^a   De smet, Anne Marie G A ^b   Kesecioglu, Jozef ^a   Bonten, Marc J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Antibiotic resistance; ICUs; SDD; Selective decontamination

Indexed keywords

CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; GENTAMICIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; ASEPSIS; BACTERIAL COLONIZATION; CLUSTER ANALYSIS; ENTEROBACTERIACEAE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; INTESTINE; MAJOR CLINICAL STUDY; NONHUMAN; SELECTIVE DIGESTIVE TRACT DECONTAMINATION; STATISTICAL SIGNIFICANCE;

ANTI-BACTERIAL AGENTS; ANTISEPSIS; BETA-LACTAM RESISTANCE; CEPHALOSPORINS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; GASTROINTESTINAL TRACT; HUMANS; INTENSIVE CARE UNITS; RECTUM;

EID: 84865389192     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks187     Document Type: Article

References (12)

1. Knothe H, Shah P, Krcmery V et al. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 1983; 11: 315-7.
2. Morel CM, Mossialos E. Stoking the antibiotic pipeline. BMJ 2010; 340: c2115.
3. de Smet AM, Kluytmans JA, Blok HE et al. Selective digestive tract decontamination and selective oropharyngeal decontamination and antibiotic resistance in patients in intensive-care units: an open-label, clustered group-randomised, crossover study. Lancet Infect Dis 2011; 11: 372-80.
4. de Smet AM, Kluytmans JA, Cooper BS et al. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 2009; 360: 20-31.
5. de Jonge E, Schultz MJ, Spanjaard L et al. Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. Lancet 2003; 362: 1011-6.
6. Brun-Buisson C, Legrand P, Rauss A et al. Intestinal decontamination for control of nosocomial multiresistant gram-negative bacilli. Study of an outbreak in an intensive care unit. Ann Intern Med 1989; 110: 873-81.
7. Oostdijk EA, de Smet AM, Kesecioglu J et al. The role of intestinal colonization with gram-negative bacteria as a source for intensive care unit-acquired bacteremia. Crit Care Med 2011; 39: 961-6.
8. Giamarellou H, Poulakou G. Multidrug-resistant Gram-negative infections: what are the treatment options? Drugs 2009; 69: 1879-901.
9. Moon YS, Chung KC, Gill MA. Pharmacokinetics of meropenem in animals, healthy volunteers, and patients. Clin Infect Dis 1997; 24 Suppl 2: S249-55.
10. Rodvold KA, Gotfried MH, Cwik M et al. Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose. J Antimicrob Chemother 2006; 58: 1221-9.
11. Abecasis F, Sarginson RE, Kerr S et al. Is selective digestive decontamination useful in controlling aerobic gram-negative bacilli producing extended spectrum b-lactamases? Microb Drug Resist 2011; 17: 17-23.
12. Buehlmann M, Bruderer T, Frei R et al. Effectiveness of a new decolonisation regimen for eradication of extended-spectrum b-lactamase-producing Enterobacteriaceae. J Hosp Infect 2011; 77: 113-7.